Eric Quéméneur
Chief Tech/Sci/R&D Officer chez TRANSGENE
Postes actifs de Eric Quéméneur
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TRANSGENE | Chief Tech/Sci/R&D Officer | 01/09/2014 | - |
| ELSALYS BIOTECH | Director/Board Member | - | - |
| Chief Tech/Sci/R&D Officer | - | - |
Historique de carrière de Eric Quéméneur
Anciens postes connus de Eric Quéméneur
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Comité de l’énergie Atomique | Corporate Officer/Principal | 01/09/2010 | 01/09/2014 |
Formation de Eric Quéméneur
| Université Claude Bernard Lyon 1 | Doctorate Degree |
| Institut National des Sciences Appliquées de Lyon | Undergraduate Degree |
Statistiques
Internationale
| France | 6 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
| Government | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TRANSGENE | Health Technology |
| Entreprise privées | 2 |
|---|---|
| Comité de l’énergie Atomique | Government |
ElsaLys Biotech SAS
 ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology ElsaLys Biotech SAS provides therapeutic monoclonal antibody player services. It involves in cellular events at the core of the pathological process: immune response, angiogenesis, survival, proliferation, adhesion and migration. The company also designs and develops a new generation of antibodies that target tumors and their immune microenvironment. ElsaLys Biotech was founded by Christine Guillen, Thierry Menguy, Vanessa Duong, and Martine Brandt in 2013 and is headquartered in Lyon, France. | Health Technology |
- Bourse
- Insiders
- Eric Quéméneur
- Expérience
